A Novel Ibs Diagnostic Blood Panel Can Enhance A Positive Diagnostic Strategy Versus A Strategy Of Exclusion For Patients With Diarrhea Predominant Irritable Bowel Syndrome (Ibs-D)- Cost Implications For Denmark
Abstract
Authors
C Purdy PM Bytzer M Pimentel R Magar